WHO ICTRP trial
Clinical trial of the efficacy and safety of nicotinamide in patients with…
CTIS2023-504100-28-00 · EU Clinical Trials Information System · Recruiting
Key facts
| Trial ID | CTIS2023-504100-28-00 |
|---|---|
| Public title | Clinical trial of the efficacy and safety of nicotinamide in patients with diabetes mellitus type 2 and liver fibrosis |
| Scientific title | Randomized, double-blind, placebo-controlled study of the efficacy and safety of nicotinamide in patients with diabetes mellitus type 2 and liver fibrosis - IIBSP-NIC-2021-157 |
| Primary sponsor | Fundacio Institut De Recerca De L Hospital De La Santa Creu I Sant Pau |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use - (Phase IV): no |
| Countries | Spain |
| Conditions | Hepatic fibrosis MedDRA version: 20.0Level: PTClassification code: 10019668Term: Hepatic fibrosisSystem Organ Class: 100000004871;Therapeutic area: Diseases [C] - Digestive System Diseases [C06];MedDRA version: 20.0Level: PTClassification… |
| Interventions | Product Code: SCP154497,Pharmaceutical Form: ,Other descriptive name: |
| Registration date | Jul 3, 2023 |
| Target size | 30 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: